San Francisco Bay Area biotech stories.
Wednesday, March 30, 2011
NeurogesX loses $12M in Q4, $44M in 2010
Pain treatment company NeurogesX Inc. lost $12.4 million in the fourth quarter and lost $44.5 million in 2010.
The San Mateo company (NASDAQ: NGSX), led by CEO and President Anthony DiTonno, lost $5.1 million in the fourth quarter of 2009.
Share to Twitter
Share to Facebook
Share to Pinterest
Post a Comment
Post Comments (Atom)